Buy & Sell Axogen Inc (AXGN) – Axogen Inc Price Today
Aura AI Summary
AXGN trades at $38.50, up 3.02% on the day, with strong analyst support (83% buy ratings) and a consensus price target of $40.67. Recent earnings beat expectations in Q2 and Q3 2025 but missed in Q4, while Q1 2026 results are pending. The company reported 21% revenue growth in 2025 but negative profit margins, highlighting a growth-focused yet unprofitable phase. Key developments include FDA BLA approval for Avance, boosting reimbursement momentum and supporting 18% growth guidance.
Outlook: AXGN offers growth potential driven by FDA approvals and market expansion, but risks include sustained profitability challenges and execution hurdles. Investors should weigh high valuation multiples against revenue growth trajectory and monitor upcoming Q1 earnings for margin improvement signals.
Key Stats
- $2.00BMarket Cap
- TechnologySector
- -19.3%3M Drawdown
- $2.02BEnterprise Value
- -Dividend Yield
52W Low: $9.29
18 Jun 2025
52W High: $38.5
17 Apr 2026
Axogen Inc (AXGN) is currently valued at a market capitalization of $2.00B, with an enterprise value of $2.02B. Over the past 52 weeks, Axogen Inc has traded between a low of $9.29 and a high of $38.5, highlighting its annual price range. Over the past three months, Axogen Inc has recorded a drawdown of -19.3%, reflecting recent price volatility.
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Technical Indicators
|
|
|
Overall Summary
Bearish (7)Neutral (11)Bullish (5)
News
People also bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions